Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Ian Robins
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Procedures
Disorders
Chemicals & Drugs
Concepts & Ideas
Living Beings
Physiology
Anatomy
Sign-in to see full Profile
Network (preview)
23
Katschinski, Dörthe
17
Prados, Michael
17
Kuhn, John
15
Mehta, Minesh
15
Chang, Susan
15
d'Oleire, FR
11
Cloughesy, Timothy
10
Wen, Patrick
10
Wiedemann, G l
10
Schiff, David
9
Yung, Alfred
9
Mehta, Minesh
9
Junck, Larry
8
Greenberg, Harry
8
Fink, Karen
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Ian Robins (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Videtic Gregory M M; Gaspar Laurie E; Aref Amr M; Germano Isabelle M; Goldsmith Brian J; Imperato Joseph P; Marcus Karen J; McDermott Michael W; McDonald Mark W; Patchell Roy A; Robins H Ian; Rogers C Leland; Suh John H; Wolfson Aaron H; Wippold Franz J
American College of Radiology appropriateness criteria on multiple brain metastases.
International journal of radiation oncology, biology, physics 2009;75(4):961-5.
-
2009: Robins H Ian; Holen Kyle D
More on reports of esophageal cancer with oral bisphosphonate use.
The New England journal of medicine 2009;360(17):1790; author reply 1791-2.
-
2009: Richards Gregory M; Tomé Wolfgang A; Robins H Ian; Stewart James A; Welsh James S; Mahler Peter A; Howard Steven P
Pulsed reduced dose-rate radiotherapy: a novel locoregional retreatment strategy for breast cancer recurrence in the previously irradiated chest wall, axilla, or supraclavicular region.
Breast cancer research and treatment 2009;114(2):307-13.
-
2008: Choi Brian; Robins H Ian; Schiller Joan; Mehta Minesh
A phase I study of gemcitabine plus palliative radiation therapy for advanced lung cancer.
Cancer chemotherapy and pharmacology 2008;63(1):175-9.
-
2008: Chang Susan M; Lamborn Kathleen R; Kuhn John G; Yung W K Alfred; Gilbert Mark R; Wen Patrick Y; Fine Howard A; Mehta Minesh P; DeAngelis Lisa M; Lieberman Frank S; Cloughesy Timothy F; Robins H Ian; Abrey Lauren E; Prados Michael D;
Neurooncology clinical trial design for targeted therapies: lessons learned from the North American Brain Tumor Consortium.
Neuro-oncology 2008;10(4):631-42.
-
2008: Robins H Ian; O'Neill Anne; Gilbert Mark; Olsen Mark; Sapiente Ronald; Berkey Brian; Mehta Minesh
Effect of dalteparin and radiation on survival and thromboembolic events in glioblastoma multiforme: a phase II ECOG trial.
Cancer chemotherapy and pharmacology 2008;62(2):227-33.
-
2008: Knisely Jonathan P S; Berkey Brian; Chakravarti Arnab; Yung Al W K; Curran Walter J; Robins H Ian; Movsas Benjamin; Brachman David G; Henderson Randall H; Mehta Minesh P
A phase III study of conventional radiation therapy plus thalidomide versus conventional radiation therapy for multiple brain metastases (RTOG 0118).
International journal of radiation oncology, biology, physics 2008;71(1):79-86.
-
2008: Corn Benjamin W; Moughan Jennifer; Knisely Jonathan P S; Fox Sherry W; Chakravarti Arnab; Yung W K Alfred; Curran Walter J; Robins H Ian; Brachman David G; Henderson Randal H; Mehta Minesh P; Movsas Benjamin
Prospective evaluation of quality of life and neurocognitive effects in patients with multiple brain metastases receiving whole-brain radiotherapy with or without thalidomide on Radiation Therapy Oncology Group (RTOG) trial 0118.
International journal of radiation oncology, biology, physics 2008;71(1):71-8.
-
2008: Prados Michael D; Yung W K A; Wen Patrick Y; Junck Larry; Cloughesy Timothy; Fink Karen; Chang Susan; Robins H Ian; Dancey Janet; Kuhn John
Phase-1 trial of gefitinib and temozolomide in patients with malignant glioma: a North American brain tumor consortium study.
Cancer chemotherapy and pharmacology 2008;61(6):1059-67.
-
2008: Lamborn Kathleen R; Yung W K Alfred; Chang Susan M; Wen Patrick Y; Cloughesy Timothy F; DeAngelis Lisa M; Robins H Ian; Lieberman Frank S; Fine Howard A; Fink Karen L; Junck Larry; Abrey Lauren; Gilbert Mark R; Mehta Minesh; Kuhn John G; Aldape Kenneth D; Hibberts Janelle; Peterson Pamela M; Prados Michael D;
Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas.
Neuro-oncology 2008;10(2):162-70.
-
2008: Choi Brian S; Robins H Ian
Reversible paclitaxel-induced vocal cord paralysis with later recall with vinorelbine.
Cancer chemotherapy and pharmacology 2008;61(2):345-6.
-
2007: Kuhn John G; Chang Susan M; Wen Patrick Y; Cloughesy Timothy F; Greenberg Harry; Schiff David; Conrad Charles; Fink Karen L; Robins H Ian; Mehta Minesh; DeAngelis Lisa; Raizer Jeffrey; Hess Kenneth; Lamborn Kathleen R; Dancey Janet; Prados Michael D;
Pharmacokinetic and tumor distribution characteristics of temsirolimus in patients with recurrent malignant glioma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(24):7401-6.
-
2007: Chang Julie E; Khuntia Deepak; Robins H Ian; Mehta Minesh P
Radiotherapy and radiosensitizers in the treatment of glioblastoma multiforme.
Clinical advances in hematology & oncology : H&O 2007;5(11):894-902, 907-15.
-
2007: Cannon George M; Tomé Wolfgang A; Robins H Ian; Howard Steven P
Pulsed reduced dose-rate radiotherapy: case report : a novel re-treatment strategy in the management of recurrent glioblastoma multiforme.
Journal of neuro-oncology 2007;83(3):307-11.
-
2007: Choi Brian S; Robins H Ian
Primary disease resection in metastatic breast cancer improves survival.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(5):603-4; author reply 604.
-
2007: Chang Julie E; Robins H Ian; Mehta Minesh P
Therapeutic advances in the treatment of brain metastases.
Clinical advances in hematology & oncology : H&O 2007;5(1):54-64.
-
2007: Robins H Ian; Chang Susan; Butowski Nicholas; Mehta Minesh
Therapeutic advances for glioblastoma multiforme: current status and future prospects.
Current oncology reports 2007;9(1):66-70.
-
2006: Robins H Ian; Traynor Anne M; Mehta Minesh
Temozolomide as prophylaxis for brain metastasis in non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2006;1(7):732-3; author reply 733.
-
2006: Cloughesy Timothy F; Wen Patrick Y; Robins H Ian; Chang Susan M; Groves Morris D; Fink Karen L; Junck Larry; Schiff David; Abrey Lauren; Gilbert Mark R; Lieberman Frank; Kuhn John; DeAngelis Lisa M; Mehta Minesh; Raizer Jeff J; Yung W K Alfred; Aldape Ken; Wright John; Lamborn Kathleen R; Prados Michael D
Phase II trial of tipifarnib in patients with recurrent malignant glioma either receiving or not receiving enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(22):3651-6.
-
2006: Robins H Ian; Brandt Kimberly; Longo Walter L
Pathophysiology and management of fever revisited.
The journal of supportive oncology 2006;4(6):265-6; author reply 266.
-
2006: Prados Michael D; Lamborn Kathleen; Yung W K A; Jaeckle Kurt; Robins H Ian; Mehta Minesh; Fine Howard A; Wen Patrick Y; Cloughesy Timothy; Chang Susan; Nicholas M Kelly; Schiff David; Greenberg Harry; Junck Larry; Fink Karen; Hess Ken; Kuhn John;
A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study.
Neuro-oncology 2006;8(2):189-93.
-
2006: Robins H Ian; Won M; Seiferheld Wendy F; Schultz Christopher J; Choucair Ali K; Brachman David G; Demas William F; Mehta Minesh P
Phase 2 trial of radiation plus high-dose tamoxifen for glioblastoma multiforme: RTOG protocol BR-0021.
Neuro-oncology 2006;8(1):47-52.
-
2005: Cloughesy Timothy F; Kuhn John; Robins H Ian; Abrey Lauren; Wen Patrick; Fink Karen; Lieberman Frank S; Mehta Minesh; Chang Susan; Yung Alfred; DeAngelis Lisa; Schiff David; Junck Larry; Groves Morris; Paquette Steve; Wright John; Lamborn Kathleen; Sebti Said M; Prados Michael
Phase I trial of tipifarnib in patients with recurrent malignant glioma taking enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(27):6647-56.
-
2005: Chang Susan M; Wen Patrick; Cloughesy Timothy; Greenberg Harry; Schiff David; Conrad Charles; Fink Karen; Robins H Ian; De Angelis Lisa; Raizer Jeffrey; Hess Kenneth; Aldape Ken; Lamborn Kathleen R; Kuhn John; Dancey Janet; Prados Michael D;
Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme.
Investigational new drugs 2005;23(4):357-61.
-
2004: Chang Susan M; Kuhn John; Wen Patrick; Greenberg Harry; Schiff David; Conrad Charles; Fink Karen; Robins H Ian; Cloughesy Timothy; De Angelis Lisa; Razier Jeffrey; Hess Kenneth; Dancey Janet; Prados Michael D;
Phase I/pharmacokinetic study of CCI-779 in patients with recurrent malignant glioma on enzyme-inducing antiepileptic drugs.
Investigational new drugs 2004;22(4):427-35.
-
2004: Schulz Craig A; Mehta Minesh P; Badie Benham; McGinn Cornelius J; Robins H Ian; Hayes Lori; Chappell Rick; Volkman Jen; Binger Kim; Arzoomanian Rhoda; Simon Kris; Alberti Dona; Feierabend Christine; Tutsch Kendra D; Kunugi Keith A; Wilding George; Kinsella Timothy J
Continuous 28-day iododeoxyuridine infusion and hyperfractionated accelerated radiotherapy for malignant glioma: a phase I clinical study.
International journal of radiation oncology, biology, physics 2004;59(4):1107-15.
-
2004: Chang Susan M; Prados Michael D; Yung W K Alfred; Fine Howard; Junck Larry; Greenberg Harry; Robins H Ian; Mehta Minesh; Fink Karen L; Jaeckle Kurt A; Kuhn John; Hess Kenneth; Schold Clifford
Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma: a North American Brain Tumor Consortium Trial.
Cancer 2004;100(8):1712-6.
-
2004: Prados Michael D; Yung W K A; Jaeckle Kurt A; Robins H Ian; Mehta Minesh P; Fine Howard A; Wen Patrick Y; Cloughesy Timothy F; Chang Susan M; Nicholas M Kelly; Schiff David; Greenberg Harry S; Junck Larry; Fink Karen L; Hess Kenneth R; Kuhn John;
Phase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study.
Neuro-oncology 2004;6(1):44-54.
-
2004: Prados Michael D; Yung W K Alfred; Fine Howard A; Greenberg Harry S; Junck Larry; Chang Susan M; Nicholas M Kelly; Robins H Ian; Mehta Minesh P; Fink Karen L; Jaeckle Kurt A; Kuhn John; Hess Kenneth R; Schold S Clifford;
Phase 2 study of BCNU and temozolomide for recurrent glioblastoma multiforme: North American Brain Tumor Consortium study.
Neuro-oncology 2004;6(1):33-7.
-
2004: Schold S Clifford; Kokkinakis Demetrius M; Chang Susan M; Berger Mitchel S; Hess Kenneth R; Schiff David; Robins H Ian; Mehta Minesh P; Fink Karen L; Davis R L; Prados Michael D
O6-benzylguanine suppression of O6-alkylguanine-DNA alkyltransferase in anaplastic gliomas.
Neuro-oncology 2004;6(1):28-32.
-
2003: Robins H Ian; Peterson Christopher G; Mehta Minesh P
Combined modality treatment for central nervous system malignancies.
Seminars in oncology 2003;30(4 Suppl 9):11-22.
-
2003: Bakhshandeh A; Bruns I; Traynor A; Robins H I; Eberhardt K; Demedts A; Kaukel E; Koschel G; Gatzemeier U; Kohlmann Th; Dalhoff K; Ehlers E M; Gruber Y; Zumschlinge R; Hegewisch-Becker S; Peters S O; Wiedemann G J
Ifosfamide, carboplatin and etoposide combined with 41.8 degrees C whole body hyperthermia for malignant pleural mesothelioma.
Lung cancer (Amsterdam, Netherlands) 2003;39(3):339-45.
-
2003: Westermann A M; Wiedemann G J; Jager E; Jager D; Katschinski D M; Knuth A; Vörde Sive Vörding P Z; Van Dijk J D P; Finet J; Neumann A; Longo W; Bakhshandeh A; Tiggelaar C L; Gillis W; Bailey H; Peters S O; Robins H I;
A Systemic Hyperthermia Oncologic Working Group trial. Ifosfamide, carboplatin, and etoposide combined with 41.8 degrees C whole-body hyperthermia for metastatic soft tissue sarcoma.
Oncology 2003;64(4):312-21.
-
2002: Robins H Ian; Chang Susan M; Prados Michael D; Yung W K Alfred; Hess Kenneth; Schiff David; Greenberg Harry; Fink Karen; Nicolas Kelly; Kuhn John G; Cloughesy Timothy; Junck Larry; Mehta Minesh
A phase II trial of thymidine and carboplatin for recurrent malignant glioma: a North American Brain Tumor Consortium Study.
Neuro-oncology 2002;4(2):109-14.
-
2002: Robins H Ian; Liu Glenn; Hayes Lori; Mehta Minesh
Trastuzumab for breast cancer-related carcinomatous meningitis.
Clinical breast cancer 2002;2(4):316.
-
2001: Katschinski D M; Jacobson E L; Wiedemann G J; Robins H I
Modulation of VP-16 cytotoxicity by carboplatin and 41.8 degrees C hyperthermia.
Journal of cancer research and clinical oncology 2001;127(7):425-32.
-
2001: Westermann A M; Grosen E A; Katschinski D M; Jäger D; Rietbroek R; Schink J C; Tiggelaar C L; Jäger E; Zum Vörde sive Vörding P; Neuman A; Knuth A; Van Dijk J D; Wiedemann G J; Robins H I
A pilot study of whole body hyperthermia and carboplatin in platinum-resistant ovarian cancer.
European journal of cancer (Oxford, England : 1990) 2001;37(9):1111-7.
-
2001: Chang S M; Kuhn J G; Robins H I; Schold S C; Spence A M; Berger M S; Mehta M; Pollack I F; Rankin C; Prados M D
A Phase II study of paclitaxel in patients with recurrent malignant glioma using different doses depending upon the concomitant use of anticonvulsants: a North American Brain Tumor Consortium report.
Cancer 2001;91(2):417-22.
-
2001: Rao R D; Robins H I
Non-Hodgkin's tumor and Pancoast's syndrome.
Oncology reports 2001;8(1):165-6.
-
2001: Rao R D; Robins H I; Mehta M P
Late recurrence of a primitive neuro-ectodermal tumor.
Oncology 2001;61(3):189-91.
-
2000: Gerke P; Filejski W; Robins H I; Wiedemann G J; Steinhoff J
Nephrotoxicity of ifosfamide, carboplatin and etoposide (ICE) alone or combined with extracorporeal or radiant-heat-induced whole-body hyperthermia.
Journal of cancer research and clinical oncology 2000;126(3):173-7.
-
2000: Schold S C; Kuhn J G; Chang S M; Bosik M E; Robins H I; Mehta M P; Spence A M; Fulton D; Fink K L; Prados M D
A phase I trial of 1,3-bis(2-chloroethyl)-1-nitrosourea plus temozolomide: a North American Brain Tumor Consortium study.
Neuro-oncology 2000;2(1):34-9.
-
1999: Robins H I; Grosen E; Katschinski D M; Longo W; Tiggelaar C L; Kutz M; Winawer J; Graziano F
Whole body hyperthermia induction of soluble tumor necrosis factor receptors: implications for rheumatoid diseases.
The Journal of rheumatology 1999;26(12):2513-6.
-
1999: Robins H I; Tutsch K; Katschinski D M; Jacobson E; Mehta M; Olsen M; Cohen J D; Tiggelaar C L; Arzoomanian R Z; Alberti D; Feierabend C; Wilding G
Phase I trial of intravenous thymidine and carboplatin in patients with advanced cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(9):2922-31.
-
1999: Katschinski D M; Robins H I; Schad M; Frede S; Fandrey J
Role of tumor necrosis factor alpha in hyperthermia-induced apoptosis of human leukemia cells.
Cancer research 1999;59(14):3404-10.
-
1999: Katschinski D M; Wiedemann G J; Longo W; d'Oleire F R; Spriggs D; Robins H I
Whole body hyperthermia cytokine induction: a review, and unifying hypothesis for myeloprotection in the setting of cytotoxic therapy.
Cytokine & growth factor reviews 1999;10(2):93-7.
-
1999: Chang S M; Kuhn J G; Robins H I; Schold S C; Spence A M; Berger M S; Mehta M P; Bozik M E; Pollack I; Schiff D; Gilbert M; Rankin C; Prados M D
Phase II study of phenylacetate in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(3):984-90.
-
1999: Katschinski D M; Robins H I
Hyperthermic modulation of SN-38-induced topoisomerase I DNA cross-linking and SN-38 cytotoxicity through altered topoisomerase I activity.
International journal of cancer. Journal international du cancer 1999;80(1):104-9.
-
1999: Katschinski D M; Benndorf R; Wiedemann G J; Mulkerin D L; Touhidi R; Robins H I
Heat shock protein antibodies in sarcoma patients undergoing 41.8 degrees C whole body hyperthermia.
Journal of immunotherapy (Hagerstown, Md. : 1997) 1999;22(1):67-70.
-
1999: Tutsch K D; Arzoomanian R Z; Alberti D; Tombes M B; Feierabend C; Robins H I; Spriggs D R; Wilding G
Phase I clinical and pharmacokinetic study of an one-hour infusion of ormaplatin (NSC 363812).
Investigational new drugs 1999;17(1):63-72.
-
1999: Robins H I; Katschinski D M; Longo W; Grosen E; Wilding G; Gillis W; Kraemer C; Tiggelaar C L; Rushing D; Stewart J A; Spriggs D; Love R; Arzoomanian R Z; Feierabend C; Alberti D; Morgan K; Simon K; d'Oleire F
A pilot study of melphalan, tumor necrosis factor-alpha and 41.8 degrees C whole-body hyperthermia.
Cancer chemotherapy and pharmacology 1999;43(5):409-14.
-
1998: Graziano F M; Katschinski D M; Robins H I
Hyperthermia and AIDS: a critical review.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1998;14(4):417-9.
-
1998: Chang S M; Kuhn J G; Rizzo J; Robins H I; Schold S C; Spence A M; Berger M S; Mehta M P; Bozik M E; Pollack I; Gilbert M; Fulton D; Rankin C; Malec M; Prados M D
Phase I study of paclitaxel in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(6):2188-94.
-
1998: Brauer L P; Prieshof B; Wiedemann G J; Weiss C; Kriz W; Schramm U; Robins H I; Pagel H
Whole-body hyperthermia combined with ifosfamide and carboplatin causes hypotension and nephrotoxicity.
Journal of cancer research and clinical oncology 1998;124(10):549-54.
-
1997: Katschinski D M; Wiedemann G J; Mentzel M; Mulkerin D L; Touhidi R; Robins H I
Influence of circadian rhythm on 41.8 degrees C whole body hyperthermia induction of haematopoietic growth factors.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1997;13(6):571-6.
-
1997: Katschinski D M; Jelkmann W; Wiedemann G J; Mentzel M; Mulkerin D L; Touhidi R; Robins H I
Dynamic changes in serum erythropoietin levels in solid tumour patients undergoing 41.8 degrees C whole body hyperthermia and/or chemotherapy.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1997;13(6):563-9.
-
1997: Robins H I; Katschinski D M; d'Oleire F; Mulkerin D; Wiedemann G J
Lack of evidence for whole body hyperthermia-induced changes in MHC and non-MHC immunological function via cytokine induction.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1997;13(5):560-2.
-
1997: Rietbroek R C; Katschinski D M; Reijers M H; Robins H I; Geerdink A; Tutsch K; d'Oleire F; Haveman J
Lack of thermal enhancement for taxanes in vitro.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1997;13(5):525-33.
-
1997: Wiedemann G J; Robins H I; Katschinski D M; Mentzel M; D'Oleire F; Kutz M; Wagner T
Systemic hyperthermia and ICE chemotherapy for sarcoma patients: rationale and clinical status.
Anticancer research 1997;17(4B):2899-902.
-
1997: Feyerabend T; Steeves R; Wiedemann G J; Richter E; Robins H I
Rationale and clinical status of local hyperthermia, radiation, and chemotherapy in locally advanced malignancies.
Anticancer research 1997;17(4B):2895-7.
-
1997: Robins H I; D'Oleire F; Grosen E; Spriggs D
Rationale and clinical status of 41.8 degrees C systemic hyperthermia tumor necrosis factor, and melphalan for neoplastic disease.
Anticancer research 1997;17(4B):2891-4.
-
1997: d'Oleire F; Katschinski D M; Robins H I
Murine modelling for cytokine induction.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1997;13(3):337-9.
-
1997: Katschinski D M; Wiedemann G J; Mentzel M; Mulkerin D L; Touhidi R; Robins H I
Optimization of chemotherapy administration for clinical 41.8 degrees C whole body hyperthermia.
Cancer letters 1997;115(2):195-9.
-
1997: Wiedemann G J; Katschinski D M; Mentzel M; Mulkerin D; Robins H I
Intracorporeal whole body hyperthermia: toxicity assessment.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1997;13(2):249-50.
-
1997: Robins H I; Rushing D; Kutz M; Tutsch K D; Tiggelaar C L; Paul D; Spriggs D; Kraemer C; Gillis W; Feierabend C; Arzoomanian R Z; Longo W; Alberti D; d'Oleire F; Qu R P; Wilding G; Stewart J A
Phase I clinical trial of melphalan and 41.8 degrees C whole-body hyperthermia in cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(1):158-64.
-
1997: Kutz M E; Mulkerin D L; Wiedemann G J; Katschinski D M; Robins H I
In vitro studies of the hyperthermic enhancement of activated ifosfamide (4-hydroperoxy-ifosfamide) and glucose isophosphoramide mustard.
Cancer chemotherapy and pharmacology 1997;40(2):167-71.
-
1996: Wiedemann G J; Robins H I; Gutsche S; Mentzel M; Deeken M; Katschinski D M; Eleftheriadis S; Crahé R; Weiss C; Storer B; Wagner T
Ifosfamide, carboplatin and etoposide (ICE) combined with 41.8 degrees C whole body hyperthermia in patients with refractory sarcoma.
European journal of cancer (Oxford, England : 1990) 1996;32A(5):888-92.
-
1996: Wiedemann G J; Robins H I; Katschinski D M; Mentzel M; van Heek R; Touhidi R R; Bucsky P; Gillis W; Feyerabend T; d'Oleire F; Freund C; Eleftheriadis S; Weiss C; Wagner T
[Clinical studies on combination of ifosfamide, carboplatin and etoposide (ICE) with whole body hyperthermia]
Medizinische Klinik (Munich, Germany : 1983) 1996;91(5):279-83.
-
1996: Feyerabend T; Steeves R; Wiedemann G J; Weiss C; Wagner T; Richter E; Robins H I
Local hyperthermia, radiation, and chemotherapy in locally advanced malignancies.
Oncology 1996;53(3):214-20.
-
1996: Woods J P; Schmitt-Tiggelaar C L; d'Oleire F; Rosenthal R C; Robins H I
Hematological effects of radiant heat-induced whole body hyperthermia on dogs.
Canadian journal of veterinary research = Revue canadienne de recherche vétérinaire 1996;60(1):75-8.
-
1995: Robins H I; Kutz M; Wiedemann G J; Katschinski D M; Paul D; Grosen E; Tiggelaar C L; Spriggs D; Gillis W; d'Oleire F
Cytokine induction by 41.8 degrees C whole body hyperthermia.
Cancer letters 1995;97(2):195-201.
-
1995: Robins H I; d'Oleire F; Kutz M; Bird A; Schmitt-Tiggelaar C L; Cohen J D; Spriggs D R
Cytotoxic interactions of tumor necrosis factor, melphalan and 41.8 degrees C hyperthermia.
Cancer letters 1995;89(1):55-62.
-
1995: Woods J P; Schmitt C L; Rosenthal R C; D'Oleire F; Robins H I
Canine bone marrow as a potential thermal sanctuary during the plateau phase of 41.8 degrees C whole body hyperthermia.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1995;11(1):49-57.
-
1994: d'Oleire F; Kutz M E; Bird A; Robins H I
Step down heating and melphalan: cytotoxic interactions and clinical implications.
Melanoma research 1994;4(5):303-5.
-
1994: Robins H I; Woods J P; Schmitt C L; Cohen J D
A new technological approach to radiant heat whole body hyperthermia.
Cancer letters 1994;79(2):137-45.
-
1993: Robins H I; Cohen J D; Schmitt C L; Tutsch K D; Feierabend C; Arzoomanian R Z; Alberti D; d'Oleire F; Longo W; Heiss C
Phase I clinical trial of carboplatin and 41.8 degrees C whole-body hyperthermia in cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(9):1787-94.
-
1992: Koltyn K F; Robins H I; Schmitt C L; Cohen J D; Morgan W P
Changes in mood state following whole-body hyperthermia.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1992;8(3):305-7.
-
1991: Tapazoglou E; Cohen J D; Schmitt C L; Khatana A; Sapareto S A; Robins H I
Whole body hyperthermia and carboplatin: cytotoxicity for murine leukaemia and normal marrow.
British journal of cancer 1991;64(3):528-30.
-
1991: Robins H I
Combined modality clinical trials for favorable B-cell neoplasms: lonidamine plus whole body hyperthermia and/or total body irradiation.
Seminars in oncology 1991;18(2 Suppl 4):23-7.
-
1991: Robins H I; Jonsson G G; Jacobson E L; Schmitt C L; Cohen J D; Jacobson M K
Effect of hyperthermia in vitro and in vivo on adenine and pyridine nucleotide pools in human peripheral lymphocytes.
Cancer 1991;67(8):2096-102.
-
1991: Robins H; Hugander A; Besozzi M; Schmitt C L; Martin P A; Zager L V; Grossman J
Beta-blockade during whole-body hyperthermia: a toxicity study in the dog.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1991;7(2):263-70.
-
1990: Cohen J D; Robins H I
Thermal enhancement of tetraplatin and carboplatin in human leukaemic cells.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1990;6(6):1013-7.
-
1990: Robins H I; Neuberg D S; Benson A B; Pandya K J; Tormey D C
Phase II study of lonidamine in patients with metastatic breast cancer. An Eastern Cooperative Oncology Group study.
Investigational new drugs 1990;8(4):397-9.
-
1990: Cohen J D; Robins H I
Cytotoxicity of diethyldithiocarbamate in human versus rodent cell lines.
Investigational new drugs 1990;8(2):137-42.
-
1990: Robins H I; Longo W L; Steeves R A; Cohen J D; Schmitt C L; Neville A J; O'Keefe S; Lagoni R; Riggs C
Adjunctive therapy (whole body hyperthermia versus lonidamine) to total body irradiation for the treatment of favorable B-cell neoplasms: a report of two pilot clinical trials and laboratory investigations.
International journal of radiation oncology, biology, physics 1990;18(4):909-20.
-
1989: Cohen J D; Robins H I; Schmitt C L; Tanner M A
Interactions of thymidine, hyperthermia, and cis-diammine-1,1-cyclobutane dicarboxylate platinum (II) in human T-cell leukemia.
Cancer research 1989;49(21):5805-9.
-
1989: Robins H I; Sielaff K M; Storer B; Hawkins M J; Borden E C
Phase I trial of human lymphoblastoid interferon with whole body hyperthermia in advanced cancer.
Cancer research 1989;49(6):1609-15.
-
1989: Cohen J D; Robins H I; Schmitt C L
Tumoricidal interactions of hyperthermia with carboplatin, cisplatin and etoposide.
Cancer letters 1989;44(3):205-10.
-
1988: Robins H I; Longo W L; Lagoni R K; Neville A J; Hugander A; Schmitt C L; Riggs C
Phase I trial of lonidamine with whole body hyperthermia in advanced cancer.
Cancer research 1988;48(22):6587-92.
-
1988: Robins H I; Longo W L; Steeves R A; Lagoni R K; Hugander A; Neville A J; O'Keefe S; Giese W; Schmitt C L
A pilot study of whole body hyperthermia and local irradiation for advanced non-small cell lung cancer confined to the thorax.
International journal of radiation oncology, biology, physics 1988;15(2):427-31.
-
1988: Cohen J D; Robins H I; Mulcahy R T; Gipp J J; Bouck N
Interactions between hyperthermia and irradiation in two human lymphoblastic leukemia cell lines in vitro.
Cancer research 1988;48(13):3576-80.
-
1988: Robins H I; Steeves R A; Schmitt C L; Peterson C; Martin P A
A hyperthermia study of differential sensitivity and thermotolerance in AKR murine leukemia and normal bone marrow cells.
International journal of radiation oncology, biology, physics 1988;14(5):979-82.
-
1987: Steeves R A; Robins H I; Miller K; Martin P; Shecterle L; Dennis W
Interaction of whole-body hyperthermia and irradiation in the treatment of AKR mouse leukemia.
International journal of radiation biology and related studies in physics, chemistry, and medicine 1987;52(6):935-47.
-
1987: Robins H I; Kalin N H; Shelton S E; Martin P A; Shecterle L M; Barksdale C M; Neville A J; Marshall J
Rise in plasma beta-endorphin, ACTH, and cortisol in cancer patients undergoing whole body hyperthermia.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 1987;19(9):441-3.
-
1987: Robins H I; Kalin N H; Shelton S E; Shecterle L M; Barksdale C M; Martin P A; Marshall J
Neuroendocrine changes in patients undergoing whole body hyperthermia.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1987;3(2):99-105.
-
1985: Robins H I; Dennis W H; Neville A J; Shecterle L M; Martin P A; Grossman J; Davis T E; Neville S R; Gillis W K; Rusy B F
A nontoxic system for 41.8 degrees C whole-body hyperthermia: results of a Phase I study using a radiant heat device.
Cancer research 1985;45(8):3937-44.
-
1985: Robins H I; Davis T E; Steeves R A; Hugander A; Carbone P P
New therapeutic approaches to low-grade B cell neoplasms.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1985;3(7):1042.
-
1984: Robins H I; Dennis W H; Martin P A; Sondel P M; Yatvin M B; Steeves R A
Potentiation of differential hyperthermic sensitivity of AKR leukemia and normal bone marrow cells by lidocaine or thiopental.
Cancer 1984;54(12):2831-5.
-
1984: Robins H I; Steeves R A; Shecterle L M; Martin P A; Miller K A; Paliwal B; Neville A J; Dennis W H
Whole body hyperthermia (41-42 degrees C): a simple technique for unanesthetized mice.
Medical physics 1984;11(6):833-9.
-
1984: Neville A J; Robins H I; Martin P; Gilchrist K W; Dennis W H; Steeves R A
Effect of whole body hyperthermia and BCNU on the development of radiation myelitis in the rat.
International journal of radiation biology and related studies in physics, chemistry, and medicine 1984;46(4):417-20.
-
1984: Robins H I; Dennis W H; Steeves R A; Sondel P M
A proposal for the addition of hyperthermia to treatment regimens for acute and chronic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1984;2(9):1050-6.
-
1983: Robins H I; Shecterle L M; Aubuchon J P; Paliwal B R; Davis T E; Dennis W H
Whole body hyperthermia with a microwave regional boost: unexpected toxicity in the pig.
International journal of radiation biology and related studies in physics, chemistry, and medicine 1983;44(5):469-73.
-
1983: Robins H I; Steeves R A; Clark A W; Martin P A; Miller K; Dennis W H
Differential sensitivity of AKR murine leukemia and normal bone marrow cells to hyperthermia.
Cancer research 1983;43(10):4951-5.
-
1983: Robins H I; Dennis W H; Slattery J S; Lange T A; Yatvin M B
Systemic lidocaine enhancement of hyperthermia-induced tumor regression in transplantable murine tumor models.
Cancer research 1983;43(7):3187-91.
-
1983: Robins H I; Grossman J; Davis T E; AuBuchon J P; Dennis W
Preclinical trial of a radiant heat device for whole-body hyperthermia using a porcine model.
Cancer research 1983;43(5):2018-22.
Sign-in to see more
